Longboard Pharmaceuticals Alternatives & Competitors

12 companies similar to Longboard Pharmaceuticals — We Are Committed To Transforming the Lives of Patients With Neurological and Rar...

Vistagen

Changing the trajectory of mental health care – One Mind at a Time

58 Post-IPO Equity $154.75M

South San Francisco, Unit...

Biotechnology Pharmaceutical

Compare

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Compare

Omeros Corporation

Let science lead the way

234 Grant $819.98M

Seattle, United States

Biotechnology Health Care +1

Praxis Precision Medicines, Inc.

The era of genetic neuroscience has arrived

244 IPO $1.66B

Boston, United States

Biotechnology Health Care +1

Rival Readout

Competing with Longboard Pharmaceuticals? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Vertero Therapeutics, Inc.

Pioneering science beyond the brain to treat neurodegenerative diseases at their source

12 Series C $110.90M

Woburn, United States

Biopharma Biotechnology +1

Relmada Therapeutics, Inc

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the tre...

32 Post-IPO Equity

Coral Gables, United Stat...

Biotechnology Pharmaceutical

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

Ocuphire Pharma

Restoring Vision and Clarity

15 Post-IPO Equity $24.56M

Farmington Hills, United...

Biopharma Biotechnology +1

Cerebral Therapeutics, Inc.

A clinical stage pharmaceutical company developing innovative treatments for neurological...

22 Series C $85.80M

Aurora, United States

Biotechnology Health Care +2

Applied Therapeutics, Inc.

45 Post-IPO Equity $419.07M

New York, United States

Biotechnology Health Care +1

About Longboard Pharmaceuticals

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company with a mission to revolutionize the lives of patients affected by neurological and rare diseases. The company is dedicated to developing groundbreaking medications for neurological conditions by focusing on a portfolio of centrally acting pro...

Business keywords

Biopharmaceutical Company, Clinical-stage, Neurological Diseases, G Protein-coupled Receptors, Small Molecule Product Candidates, 5-hydroxytryptamine 2C (5-HT2C) Receptor, Epileptic Encephalopathies, Sphingosine-1-phosphate (S1P) Receptor, Multiple Neurological Diseases, Cannabinoid Type 2 Receptor (CB2), Central Nervous System (CNS), Drug Development, Clinical Trials, Neurological Research, Translational Medicine

Frequently Asked Questions

Companies similar to Longboard Pharmaceuticals include Vistagen, Cascadian Therapeutics, Inc., Omeros Corporation, Praxis Precision Medicines, Inc., ORIC Pharmaceuticals Inc.. They work in Biotechnology and Pharmaceutical and share Longboard Pharmaceuticals's focus on clinical trials, drug development and clinical-stage.

Bounce Watch lists 12 companies that share Longboard Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Longboard Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Longboard Pharmaceuticals Profile Vistagen Alternatives Cascadian Therapeutics, Inc. Alternatives Omeros Corporation Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Longboard Pharmaceuticals on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.